Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 3/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.48 |
| ▸ | GSR | P00390 | 2/20 | 0.48 |
| ▸ | GRM8 | O00222 | 1/20 | 0.48 |
| ▸ | GRM6 | O15303 | 1/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.48 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.48 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.48 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.48 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.48 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.48 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.48 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.48 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL666790 | 1.00 | GRIK1 (0.48) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| Trifluoroacetic Acid SCHEMBL30280654 | 0.91 | GRIK1 (0.41) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| Trifluoroacetic Acid SCHEMBL28528219 | 0.89 | GRIK1 (0.40) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL176227 | 0.87 | TSHR (0.47) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL3968417 | 0.87 | TSHR (0.47) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL176229 | 0.87 | TSHR (0.47) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL31714254 | 0.87 | GRIK1 (0.43) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL6422885 | 0.86 | TSHR (0.46) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL5141195 | 0.86 | TSHR (0.46) | GRIK1GRIK2SLC1A1GSRGRM8 | |
| SCHEMBL28276401 | 0.83 | TSHR (0.50) | BLMKMT2ATSHRTDP1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | claimed |
| EP-4493273-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | Politechnika Wroclawska (PL) | 2025-01-22 | — | — | EP | claimed |
| WO-2024073333-A1 | HARD SURFACE CLEANING COMPOSITIONS COMPRISING RHAMNOLIPIDS AND GLUTAMATE CO-SURFACTANT | STEPAN COMPANY (US) | 2024-04-04 | — | — | WO | claimed |
| WO-2024002698-A1 | COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR IMPROVED ANTIOXIDANT EFFECTS | BASF SE (DE) | 2024-01-04 | — | — | WO | claimed |
| WO-2023175356-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | POLITECHNIKA WROCLAWSKA (PL) | 2023-09-21 | — | — | WO | claimed |
| WO-2023053960-A1 | SKIN EXTERNAL AGENT CONTAINING 12-HYDROXYSTEARIC ACID AND HAVING α-GEL STRUCTURE | 株式会社 資生堂 | 2023-04-06 | — | — | WO | claimed |
| EP-3621578-B1 | LOW VISCOSITY, HIGH POLYOL SELF-FOAMING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2022-02-16 | — | — | EP | claimed |
| EP-3902899-A1 | HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-11-03 | — | — | EP | claimed |
| CN-113227339-A | Home care compositions | 高露洁-棕榄公司 | 2021-08-06 | — | — | CN | claimed |
| US-10975332-B2 | Home care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2021-04-13 | — | — | US | claimed |
| US-5840671-A | TERTIARY AMINE OXIDE | TOMEY TECHNOLOGY CORPORATION (JP) | 1998-11-24 | — | — | US | claimed |
| EP-0717101-A1 | Cleaning solution for contact lens | TOMEY TECHNOLOGY CORPORATION (JP) | 1996-06-19 | — | — | EP | claimed |
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | claimed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | claimed |
| US-4976962-A | Biodegradable polypeptide and the use thereof for the gradual release of drugs | BRACCO RESEARCH S.A. (CH) | 1990-12-11 | — | — | US | claimed |
| US-4892733-A | DRUG DELIVERY, HOMO-AND CO-POLYMERS OF ASPARTIC AND GLUTAMIC ACID | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-01-09 | — | — | US | claimed |
| US-4888398-A | ALKYL- OR ACRYLOXYCARBONYLMETHYL POLYASPARTATE AND POLYGLUTAMATE | BATTELLE MEMORIAL INSTITUTE (CH) | 1989-12-19 | — | — | US | claimed |
| EP-0213996-B1 | RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-09-06 | — | — | EP | claimed |
| US-4675381-A | Biodegradable polypeptide and its use for the gradual release of drugs | BATTELLE MEMORIAL INSTITUTE (CH) | 1987-06-23 | — | — | US | claimed |
| EP-0130935-B1 | BIODEGRADABLE POLYPEPTIDE AND ITS USE IN THE SUSTAINED RELEASE OF MEDICAMENTS | BATTELLE MEMORIAL INSTITUTE (CH) | 1987-04-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | F11, F2, F12 | GRIK1 4184/4885GRIK2 4711/4885SLC1A1 4491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.